PLGA-PEG-Folate

Price range: $360.00 through $650.00

PLGA-PEG-Folate is a biodegradable amphiphilic block copolymer consisting of poly(lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG), and a folic acid targeting ligand. The hydrophobic PLGA segment enables drug encapsulation and controlled release, the PEG spacer improves aqueous solubility and biocompatibility, and the folate moiety facilitates receptor-mediated targeting of folate receptor-overexpressing cells. PLGA-PEG-Folate is widely used in targeted drug delivery, cancer therapeutics, nanoparticle engineering, and nanomedicine research.

Product Specifications

Product Name: PLGA-PEG-Folate
Polymer Composition: Poly(lactic-co-glycolic acid)-Polyethylene Glycol-Folic Acid
PLGA Molecular Weight: 1k, 2k, 5k, 10k, 15k, 20k, 30k Da, Custom
PEG Molecular Weight: 1k, 2k, 3.4k, 5k, 10k Da
Lactide Ratio: 50:50, 65:35, 75:25, 85:15, Custom
Functional Groups: PLGA, PEG, Folic Acid
Appearance: Yellow to orange solid
Solubility: DMSO, DMF, THF, Acetone, Dichloromethane, Chloroform
Storage: -20°C, dry and protected from light
Purity: Typically ≥90%

PLGA-PEG-Folate structure

Description

General Description

PLGA-PEG-Folate is a targeted biodegradable copolymer designed for receptor-mediated drug delivery applications. The hydrophobic PLGA segment forms the core of nanoparticles and micelles capable of encapsulating hydrophobic drugs, proteins, peptides, nucleic acids, and imaging agents, while the PEG segment forms a hydrophilic corona that enhances colloidal stability, prolongs circulation time, and reduces nonspecific protein adsorption.

The folic acid ligand exhibits high affinity toward folate receptors, which are overexpressed on numerous cancer cells including ovarian, breast, lung, kidney, colorectal, and cervical cancers. This receptor-mediated uptake pathway promotes enhanced cellular internalization and targeted delivery of therapeutic agents.

PLGA-PEG-Folate is frequently employed in targeted nanoparticle development, cancer drug delivery, molecular imaging, diagnostic applications, and advanced nanomedicine research.

Applications

  • Targeted drug delivery
  • Cancer-targeted nanoparticles
  • Nanoparticle formulation
  • Polymeric micelle preparation
  • Anticancer drug delivery
  • Molecular imaging
  • Gene delivery systems
  • Diagnostic applications
  • Tissue engineering
  • Nanomedicine research

Features and Benefits

  • Biodegradable PLGA segment
  • Hydrophilic PEG spacer
  • Folate receptor targeting ligand
  • Receptor-mediated cellular uptake
  • Excellent biocompatibility
  • Improves nanoparticle stability
  • Extends circulation time
  • Reduces protein adsorption
  • Supports controlled drug release

Additional information

PLGA Molecular Weight

2000, 5000, 10k, 20k, 30K, 40K

PEG Molecular Weight

2000, 5000

Package size

50mg, 100mg